WinstonWınston
Back
Eurobio Scientific S.A. logo

Eurobio Scientific S.A.

ALERS.PA
55
Medical - Devices · Healthcare
Price
€19.90
-0.50 (-2.45%)
Market Cap
€200.4M
Exchange
Euronext Paris
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Good

Share count falling — buybacks

5.8% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 10.9M (2021) → 10.2M (2025)

Winston Score History

The full picture

Eurobio Scientific is a French company that makes and sells medical diagnostic tools. Its products help doctors and laboratories detect diseases, monitor organ transplants, and run tests on blood and other samples. The company sells mainly to hospitals, clinical labs, and research centers across Europe.

Eurobio Scientific makes money by selling diagnostic kits, reagents, and laboratory equipment directly to healthcare customers. It operates primarily in France and other European markets, and it also distributes products from other manufacturers, which adds a second revenue stream alongside its own branded goods. The company is relatively small, with a market cap around $200 million, and its competitive position relies on specialized expertise in transplant diagnostics and infectious disease testing. A key risk is its dependence on a limited number of product lines and geographic markets, which leaves it exposed if larger global diagnostics companies increase competition or if hospital procurement budgets tighten.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

>+1,000% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€5M/ year

Flat (-1% vs prior year)

2.7% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

69.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€22M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Eurobio Scientific S.A. is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
42.6%
Healthy — 42.6% gross margin
Profit after running costs
Operating Margin
8.6%
Modest — 8.6% operating margin
Return on the money invested
ROCE
6.9%
Weak — 6.9% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+8.8%
Steady sales growth (+8.8% YoY)
Profit growth
EPS YoY
+17.5%
Earnings growing fast (+17.5% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
347%
Turns 347% of profit into real cash
Spare cash per sale
FCF Margin
2.7%
Thin free cash flow (2.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.06
Conservative — low debt load (0.06)
Covers its interest
Interest Cover
4.46x
Adequate interest coverage (4.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
42.3x
Pricey — P/E 42.3

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+24.6
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (42.3 → 17.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial